Invesco’s MaxCyte MXCT Stock Holding History
Bought
Maintained
Sold
Other funds holding MXCT
CFM
VP
MA
BFM
CCM
PLC
Invesco's MXCT Position: Q2 2026 in Review
Invesco sold out of MaxCyte (MXCT) in Q2 2026, closing a stake of 119,227 shares — an estimated $83.8K sold.
Invesco first reported a position in MXCT in Q4 2021 and held it in 18 quarters. The position peaked at $386K in Q4 2021. 122 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.
- Invesco reported no remaining MaxCyte position as of Q2 2026 after selling out during the quarter.
- Invesco sold 119,227 MaxCyte shares in Q2 2026, an estimated $83.8K.
- Invesco first reported a position in MaxCyte in Q4 2021 and held it in 18 quarters.
- Invesco's MaxCyte position peaked at $386K in Q4 2021.
- 122 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.
Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.